Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.55% |
| 2 | Consumer Discretionary | 0.95% |
| 3 | Financials | 0.77% |
| 4 | Healthcare | 0.67% |
| 5 | Industrials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
CALL
Insulet
PODD
$9.94B
| $22.2M | ﹤0.01% |
84,700
-18,500
| -18% | -$5.01M |
|
1652
CALL
Procore
PCOR
$9.18B
| $22.2M | ﹤0.01% |
336,800
-30,700
| -8% | -$2.32M |
|
1653
PUT
Credo Technology Group
CRDO
$42.2B
| $22.2M | ﹤0.01% |
553,300
+239,100
| +76% | +$14.9M |
|
1654
PUT
Commault Systems
CVLT
$5.57B
| $22.1M | ﹤0.01% |
140,400
+85,900
| +158% | +$14.1M |
|
1655
PUT
SolarEdge
SEDG
$2.04B
| $22.1M | ﹤0.01% |
1,367,400
-542,000
| -28% | -$8.43M |
|
1656
PUT
Pan American Silver
PAAS
$21.8B
| $22.1M | ﹤0.01% |
856,000
+305,200
| +55% | +$7.3M |
|
1657
McKesson
MCK
$105B
| $22.1M | ﹤0.01% |
32,853
-28,803
| -47% | -$17.8M |
|
1658
PUT
Fastenal
FAST
$58.7B
| $22.1M | ﹤0.01% |
570,200
+180,400
| +46% | +$6.76M |
|
|
BPMC
1659
CALL
DELISTED
Blueprint Medicines
BPMC
| $22.1M | ﹤0.01% |
249,600
+78,300
| +46% | +$7.64M |
|
1660
Patterson-UTI
PTEN
$4.48B
| $22.1M | ﹤0.01% |
2,686,043
-86,098
| -3% | -$722K |
|
1661
Fox Class A
FOXA
$29.3B
| $22.1M | ﹤0.01% |
389,900
+205,087
| +111% | +$10.8M |
|
1662
SS&C Technologies
SSNC
$19.5B
| $22M | ﹤0.01% |
263,957
+34,599
| +15% | +$2.86M |
|
1663
CALL
Vanguard Total World Stock ETF
VT
$81.1B
| $22M | ﹤0.01% |
189,800
+164,000
| +636% | +$19.6M |
|
1664
PUT
Direxion Daily Technology Bull 3x ETF
TECL
$5.63B
| $22M | ﹤0.01% |
375,300
+114,000
| +44% | +$9.28M |
|
1665
PUT
Weibo
WB
$1.73B
| $22M | ﹤0.01% |
2,320,700
+705,000
| +44% | +$7.16M |
|
|
SLNO
1666
PUT
DELISTED
Soleno Therapeutics
SLNO
| $21.9M | ﹤0.01% |
307,100
-1,203,900
| -80% | -$58.6M |
|
1667
PUT
Macy's
M
$6B
| $21.9M | ﹤0.01% |
1,746,300
-1,172,800
| -40% | -$17M |
|
1668
CALL
PennyMac Financial
PFSI
$3.79B
| $21.9M | ﹤0.01% |
218,500
+18,400
| +9% | +$1.89M |
|
1669
PUT
Ollie's Bargain Outlet
OLLI
$4.49B
| $21.9M | ﹤0.01% |
187,900
-106,500
| -36% | -$11.3M |
|
1670
Devon Energy
DVN
$51.5B
| $21.9M | ﹤0.01% |
584,231
-1,320,182
| -69% | -$46.9M |
|
1671
CALL
GeneDx Holdings
WGS
$2.69B
| $21.8M | ﹤0.01% |
246,400
+151,500
| +160% | +$13.1M |
|
1672
Ares Management
ARES
$32B
| $21.8M | ﹤0.01% |
148,791
+38,235
| +35% | +$6.61M |
|
1673
Fidelity National Financial
FNF
$12.7B
| $21.8M | ﹤0.01% |
334,329
-80,280
| -19% | -$4.82M |
|
1674
Parker-Hannifin
PH
$131B
| $21.7M | ﹤0.01% |
35,741
-16,779
| -32% | -$11M |
|
1675
British American Tobacco
BTI
$124B
| $21.7M | ﹤0.01% |
524,430
+508,267
| +3,145% | +$20M |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass withdrew a net $24.4B in Q1 2025, closing 1,482 positions and reducing 4,842 holdings. Its most notable exit was Inari Medical, Inc. Common Stock, an estimated $24M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 2% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jeff Yass opened a new position in Brookfield Asset Management worth $86M.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.